GE HealthCare Technologies Dividende

Zukünftiges Wachstum Kriterienprüfungen 0/6

GE HealthCare Technologies ist ein dividendenzahlendes Unternehmen mit einer aktuellen Rendite von 0.13%. Das nächste Zahlungsdatum ist am 15th November, 2024 mit einem Ex-Dividendendatum von 18th October, 2024.

Wichtige Informationen

0.1%

Dividendenausschüttung

Ausschüttungsquote

Durchschnittlicher Branchenertrag	1.7%
Nächster Dividendenzahlungstermin	15 Nov 24
Ex-Dividendendatum	18 Oct 24
Dividende pro Aktie	US$0.120
Gewinn pro Aktie	US$3.47
Prognose der Dividendenrendite	0.2%

Aktuelle Dividendenentwicklung

Recent updates

GE HealthCare: The Image Of More Upside Is Very Real

Sep 18

Are Investors Undervaluing GE HealthCare Technologies Inc. (NASDAQ:GEHC) By 28%?

Sep 05

GE HealthCare Technologies Inc.'s (NASDAQ:GEHC) Intrinsic Value Is Potentially 100% Above Its Share Price

Apr 25

GE Vernova: An Interesting Stalwart To Ride The Energy Transition

Apr 02

GE HealthCare Technologies: Growth Prospects Remain Encouraging, And Valuation Is Attractive

Mar 25

GE HealthCare Technologies' Roar Higher Isn't Over Yet

Mar 09

GE HealthCare Technologies: Stable Business, But Future Upside Seems Limited

Feb 14

GE HealthCare Q4 Earnings: Growth Lagging The Market

Feb 06

Why GE HealthCare May Be Up To 50% Undervalued

Jan 11

GE HealthCare Technologies (NASDAQ:GEHC) May Have Issues Allocating Its Capital

Jan 05

Kommende Dividendenausschüttung

Stabilität und Wachstum des Zahlungsverkehrs

Rufe Dividendendaten ab

Stabile Dividende: GEHC zahlt keine nennenswerte Dividende für den Markt US, daher muss nicht geprüft werden, ob die Zahlungen stabil sind.

Wachsende Dividende: GEHC zahlt keine nennenswerte Dividende für den Markt US, daher ist es nicht notwendig zu prüfen, ob die Zahlungen steigen.

Dividendenrendite im Vergleich zum Markt

GE HealthCare Technologies Dividendenrendite im Vergleich zum Markt

Wie sieht die Dividendenrendite von GEHC im Vergleich zum Markt aus?
Segment	Dividendenrendite
Unternehmen (GEHC)	0.1%
Untere 25 % des Marktes (US)	1.4%
Markt Top 25 % (US)	4.3%
Branchendurchschnitt (Medical Equipment)	1.7%
Analystenprognose (GEHC) (bis zu 3 Jahre)	0.2%

Bemerkenswerte Dividende: GEHCDie Dividende des Unternehmens (0.15%) ist im Vergleich zu den unteren 25 % der Dividendenzahler auf dem Markt US (1.53%) nicht bemerkenswert.

Hohe Dividende: GEHCDie Dividende des Unternehmens (0.15%) ist im Vergleich zu den besten 25% der Dividendenzahler auf dem Markt US (4.81%) niedrig.

Gewinnausschüttung an die Aktionäre

Abdeckung der Erträge: GEHC zahlt keine nennenswerte Dividende für den Markt US.

Barausschüttung an die Aktionäre

Cashflow-Deckung: GEHC zahlt keine nennenswerte Dividende für den Markt US.

GE HealthCare Technologies Dividende

Zukünftiges Wachstum Kriterienprüfungen 0/6

Wichtige Informationen

Aktuelle Dividendenentwicklung

Upcoming dividend of US$0.03 per share

GE HealthCare Technologies Inc. Announces Cash Dividend for Second Quarter of 2024, Payable on August 15, 2024

Upcoming dividend of US$0.03 per share

Upcoming dividend of US$0.03 per share at 0.2% yield

Recent updates

Second quarter dividend of US$0.03 announced

GE HealthCare Introduces Elevated Venue Point of Care Ultrasound Solutions and New Tablet-Based Venue Sprint

GE HealthCare: The Image Of More Upside Is Very Real

GE HealthCare Technologies Inc. has filed a Follow-on Equity Offering.

Are Investors Undervaluing GE HealthCare Technologies Inc. (NASDAQ:GEHC) By 28%?

GE HealthCare Technologies Inc. Showcases Latest AI-Enhanced Cardiology Solutions to Enable Real-Time Cardiac Imaging and Assessments At the Point of Care At ESC 2024

GE HealthCare Announces the Publication of the MASTER Trial Results in the Peer-Reviewed Journal Anesthesia and Analgesia

Insider recently sold US$1.6m worth of stock

GE HealthCare Q2 Earnings Recap (Rating Downgrade)

Second quarter 2024 earnings: EPS exceeds analyst expectations

GE Healthcare Technologies Inc. Updates Earnings Guidance for the Year 2024

GE Healthcare Technologies Inc. Updates Earnings Guidance for the Year 2024

Upcoming dividend of US$0.03 per share

GE HealthCare Technologies Inc. to Report Q2, 2024 Results on Jul 31, 2024

GE HealthCare: Near-Term Risks, But Some Interesting Longer-Term Opportunities

First quarter dividend of US$0.03 announced

GE HealthCare Technologies Inc. Announces Cash Dividend for Second Quarter of 2024, Payable on August 15, 2024

GE Healthcare Names Adam Holton as Chief People Officer

Is GE HealthCare Technologies (NASDAQ:GEHC) A Risky Investment?

President & CEO of Imaging notifies of intention to sell stock

GE HealthCare Unveils SIGNA MAGNUS, an FDA 510(K) Pending Head-Only Magnetic Resonance (MR) Scanner Designed to Explore Advance Advancements in Neuro Science

GE HealthCare: Too Soon To Buy After A Mixed Q1 (Rating Downgrade)

GE HealthCare Launches New Era of AI-Enhanced, Personalized Oncology Solutions at ESTRO 2024 Congress

First quarter 2024 earnings: EPS and revenues miss analyst expectations

GE HealthCare Technologies Inc. Reaffirms Earnings Guidance for the Full Year 2024

GE HealthCare Technologies Inc.'s (NASDAQ:GEHC) Intrinsic Value Is Potentially 100% Above Its Share Price

GE HealthCare Introduces AI-Enhanced Voluson Signature 20 and 18 Ultrasound Systems to Advance Women's Health Imaging

Upcoming dividend of US$0.03 per share

GE HealthCare Technologies Inc. to Report Q1, 2024 Results on Apr 30, 2024

GE HealthCare Technologies Inc., Annual General Meeting, May 21, 2024

GE Healthcare Introduces Caption AI on Vscan Air SL Wireless Handheld Ultrasound System to Help More Clinicians Capture Diagnostic-Quality Cardiac Images

GE Vernova: An Interesting Stalwart To Ride The Energy Transition

GE HealthCare Unveils AI-Enabled Urology Software Feature Prostate Volume Assist

GE HealthCare Technologies: Growth Prospects Remain Encouraging, And Valuation Is Attractive

GE HealthCare Technologies Inc. to Feature Latest Technologies in Interventional Radiology Focused on Precision Care At Sir 2024

GE HealthCare Technologies Inc. has filed a Follow-on Equity Offering.

GE HealthCare Technologies' Roar Higher Isn't Over Yet

GE HealthCare Technologies Inc. has completed a Follow-on Equity Offering in the amount of $1.06925 billion.

GE HealthCare Technologies Inc. has filed a Follow-on Equity Offering.

GE HealthCare Technologies: Stable Business, But Future Upside Seems Limited

Price target increased by 7.6% to US$90.21

Full year 2023 earnings: EPS misses analyst expectations

Now 33% overvalued after recent price rise

GE HealthCare Technologies Inc. Provides Earnings Guidance for the Full Year of 2024

GE HealthCare Q4 Earnings: Growth Lagging The Market

GE HealthCare Technologies Inc. Receives 510(K) Clearance from the United States Food and Drug Administration for Novii™+ Wireless Patch Solution

GE HealthCare Technologies Inc. Announces Prucka 3 Digital Amplifier as Next Generation Platform for Electrophysiology Innovation

GE HealthCare Technologies Inc. to Report Q4, 2023 Results on Feb 06, 2024

Why GE HealthCare May Be Up To 50% Undervalued

GE HealthCare Technologies Inc. (NasdaqGS:GEHC) entered into definitive agreement to acquire MIM Software Inc.

GE HealthCare Technologies (NASDAQ:GEHC) May Have Issues Allocating Its Capital

Upcoming dividend of US$0.03 per share at 0.2% yield

GE HealthCare Highlights Commitment to Delivering Better Patient Experiences and Outcomes Through Deep Learning at RSNA 2023

GE HealthCare Expands On-Device Triage Capabilities of Critical Care Suite with FDA Clearance of Algorithm for Pneumothorax Detection, Notification, Triage and Diagnosis

GE HealthCare Technologies Inc. Releases MyBreastAI Suite to Support Clinicians in Accelerating Breast Cancer Detection

GE Healthcare Announces New Data Validating Artificial Intelligence Models for Predicting Patient Response to Immunotherapies

GE HealthCare Technologies Inc. Provides Earnings Guidance for the Year 2023

Third quarter 2023 earnings: EPS misses analyst expectations

GE HealthCare Technologies Inc. Announces to Showcase Some of the Latest Innovations Designed to Help Clinicians in the Treatment of Cardiovascular Disease At the 2023 Transcatheter Cardiovascular Therapeutics Conference

Kommende Dividendenausschüttung

Stabilität und Wachstum des Zahlungsverkehrs

Dividendenrendite im Vergleich zum Markt

Gewinnausschüttung an die Aktionäre

Barausschüttung an die Aktionäre

Entdecken Sie dividendenstarke Unternehmen